Clinical Trial Update: Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm [NA]

View source ↗

Summary

This clinical trial update reports results for using decitabine plus cytarabine in older adults with untreated acute myeloid leukemia, high-risk myelodysplastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome
• Myelomonocytic Leukemia Type 2
• Myeloproliferative Neoplasm

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)

Snippet

Sponsor: University of Washington | Conditions: Chronic Myelomonocytic Leukemia-2, Myelodysplastic Syndrome | NA | Status: COMPLETED | Results posted: 2018-04-13